By Bioassay GmbH
To get in touch with Bioassay makes debut at Basel Festival of Biologics, simply fill out the form below.
Subscribe to Supplier
Bioassay makes debut at Basel Festival of Biologics
Heidelberg, Germany: – Specialist bioanalytical contract laboratory Bioassay GmbH will make its debut at the three-day Basel Festival of Biologics later this month.
Bioassay will be an exhibitor at the event, displaying from Stand 50 at the Basel Congress Centre. Its event team will be led by Managing Director and Chief Scientific Officer, Dr. Axel Hohenstein.
The Bioassay stand will focus on its extensive portfolio of specific peptide synthesis and analysis services, sitting alongside its potency assays and other functional bioanalytical and biopharma assays.
The Bioassay team in Basel will also use the Festival as a key networking opportunity.
“This amazing event provides a superb opportunity to identify new leads and raise awareness of Bioassay as a leading analytical service provider,” commented Dr. Hohenstein.
Bioassay GmbH is a German-based bioanalytical contract laboratory (CRO) specializing in the development, validation and routine performance of bioanalytical assays in the areas of Pharmacology and Toxicology. The company serves clients in the biotechnology, chemistry and cosmetics sectors and is particularly expert in carrying out potency assays under GMP for biopharmaceuticals, including therapeutic antibodies, hormones and cytokines.
Bioassay offers a range of services based on in-vivo and in-vitro systems including potency assays (GMP) and toxicity Studies (GLP) and has developed a range of proprietary customized, product specific, assays in accordance to ICH and FDA guidelines. Services focus on four key areas: Biopharma Potency, Biopharma Efficacy, Biopharma Safety and Chemicals / Cosmetics Safety.
Bioassay GmbH was privately founded in 2002 as a team of five people primarily focused on developing an Erythropoietin bioassay. Initially located at the BASF facilities in Ludwigshafen, Bioassay moved to its current location at Heidelberg’s Technology Park in 2005.
In early 2017, Bioassay acquired Heidelberg Technology Park neighbor PSL Peptide Specialty Laboratories GmbH (PSL), which specializes in customized peptide syntheses and peptide-specific antibodies.
About Festival of Biologics 2019
Tracing its roots back to 2004, the Festival of Biologics is Europe’s most important gathering of big pharma, biotech, academia and industry professionals.
Its mission is to bring together the full value chains from the antibodies, immunotherapy, clinical trials and biosimilars industries located in the major life science hub of Basel .
The combined three-day event opens October 15 at the Basel Congress Center, combining four conferences, the European Antibody Congress, the World Immunotherapy Congress, the World Biosimilar Congress and the Clinical Trials World Congress, along with a co-located exhibition.
Presentations for 2019 will move through the entire development pipeline and focus on commercial applications.
The event is organized by Terapinn with further information at: https://www.terrapinn.com/conference/festival-of-biologics/index.stm